Immunization against natural Helicobacter pylori infection in nonhuman primates.
- 1 September 1998
- journal article
- Vol. 66 (9) , 4340-6
Abstract
Helicobacter pylori infection is widespread in some breeding groups of a rhesus monkey colony (71% H. pylori positive by 1 year), and the rate of seroconversion is also high. As a result, these groups can be used to test the safety and efficacy of an anti-H. pylori vaccine. Nine-month-old female animals were randomized to receive either 8 mg of recombinant urease (rUre) plus 25 microg of Escherichia coli heat-labile enterotoxin (LT) (n = 26) or placebo plus LT (n = 29), given four times at 1-week intervals followed by a booster 1 month later. Ten months after the start of the immunization, the animals were subjected to endoscopy and biopsy samples were obtained. H. pylori negativity was defined as no H. pylori growth by culture and no H. pylori observed at histology. By this criterion, 2 (7%) of 29 animals receiving placebo and 8 (31%) of 26 immunized animals were H. pylori negative (P < 0.035). In addition, antral gastritis score was significantly less in H. pylori-negative immunized monkeys than in H. pylori-positive animals, whether they were given rUre plus LT or placebo plus LT (P < 0.02 or P < 0.01, respectively). Interestingly, antral gastritis was also significantly less in H. pylori-positive animals given rUre plus LT than in H. pylori-positive animals given placebo plus LT (P < 0.02). However, quantitative cultures did not demonstrate significant differences between the two latter groups. It is concluded that oral administration of rUre vaccine plus LT significantly protects nonhuman primates against H. pylori infection while not causing undesirable side effects.This publication has 36 references indexed in Scilit:
- Immunogenicity and safety of recombinantHelicobacter pylori urease in a nonhuman primateDigestive Diseases and Sciences, 1996
- Therapeutic immunization against Helicobacter infectionGastroenterology, 1996
- TheHelicobacter felisMouse Model in Assessing Anti-HelicobacterTherapies and Gastric Mucosal Prostaglandin E2LevelsScandinavian Journal of Gastroenterology, 1996
- The importance of local acid production in the distribution of Helicobacter felis in the mouse stomachGastroenterology, 1995
- Safety and immunogenicity of a prototype oral whole-cell killed Campylobacter vaccine administered with a mucosal adjuvant in non-human primatesVaccine, 1995
- New strategies for using mucosal vaccination to achieve more effective immunizationVaccine, 1994
- Protection of germ-free mice from infection by Helicobacter felis after active oral or passive IgA immunizationVaccine, 1993
- An ultrastructural study of Helicobacter mustelae and evidence of a specific association with gastric mucosaJournal of Medical Microbiology, 1992
- Opsonic Activity of Specific Human IgG against Helicobacter pyloriThe Journal of Infectious Diseases, 1990
- Local immune response to gastric Campylobacter in non-ulcer dyspepsia.Journal of Clinical Pathology, 1986